These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29029452)

  • 21. H3K27me3 is an epigenetic barrier while KDM6A overexpression improves nuclear reprogramming efficiency.
    Zhou C; Wang Y; Zhang J; Su J; An Q; Liu X; Zhang M; Wang Y; Liu J; Zhang Y
    FASEB J; 2019 Mar; 33(3):4638-4652. PubMed ID: 30673507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
    Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
    Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pluripotency factors and Polycomb Group proteins repress aryl hydrocarbon receptor expression in murine embryonic stem cells.
    Ko CI; Wang Q; Fan Y; Xia Y; Puga A
    Stem Cell Res; 2014 Jan; 12(1):296-308. PubMed ID: 24316986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
    Yamamoto M; Sakane K; Tominaga K; Gotoh N; Niwa T; Kikuchi Y; Tada K; Goshima N; Semba K; Inoue JI
    Cancer Sci; 2017 Jun; 108(6):1210-1222. PubMed ID: 28371195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KDM6A promotes chondrogenic differentiation of periodontal ligament stem cells by demethylation of SOX9.
    Wang P; Li Y; Meng T; Zhang J; Wei Y; Meng Z; Lin Y; Liu D; Sui L
    Cell Prolif; 2018 Jun; 51(3):e12413. PubMed ID: 29171124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
    Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
    Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
    Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
    J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of beta 4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition.
    Yang X; Pursell B; Lu S; Chang TK; Mercurio AM
    J Cell Sci; 2009 Jul; 122(Pt 14):2473-80. PubMed ID: 19549682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3.
    Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X
    Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysine-specific Demethylase 6A Upregulates Cadherin-1 and Accelerates Gastric Cancer Growth.
    Li D; Zhang S; Yan Q; Li Y
    Curr Pharm Biotechnol; 2023; 24(14):1827-1835. PubMed ID: 36941815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bivalent Histone Modifications and Development.
    Li F; Wan M; Zhang B; Peng Y; Zhou Y; Pi C; Xu X; Ye L; Zhou X; Zheng L
    Curr Stem Cell Res Ther; 2018; 13(2):83-90. PubMed ID: 28117006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibiting KDM6A Demethylase Represses Long Non-Coding RNA Hotairm1 Transcription in MDSC During Sepsis.
    Bah I; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    Front Immunol; 2022; 13():823660. PubMed ID: 35185915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.
    Kaukonen D; Kaukonen R; Polit L; Hennessy BT; Lund R; Madden SF
    BMC Med Genomics; 2020 Jul; 13(1):92. PubMed ID: 32620123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
    Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM
    Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
    Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
    Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KDM6A Depletion in Breast Epithelial Cells Leads to Reduced Sensitivity to Anticancer Agents and Increased TGFβ Activity.
    Xiao JF; Kua LF; Ding LW; Sun QY; Myint KN; Chia XR; Venkatachalam N; Loh X; Duex JE; Neang V; Zhou S; Li Y; Yang H; Koeffler HP; Theodorescu D
    Mol Cancer Res; 2022 Apr; 20(4):637-649. PubMed ID: 35022315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular matrix detached cancer cells resist oxidative stress by increasing histone demethylase KDM6 activity.
    Alfaleh MA; Razeeth Shait Mohammed M; Hashem AM; Abujamel TS; Alhakamy NA; Imran Khan M
    Saudi J Biol Sci; 2024 Jan; 31(1):103871. PubMed ID: 38107766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.
    Toneff MJ; Sreekumar A; Tinnirello A; Hollander PD; Habib S; Li S; Ellis MJ; Xin L; Mani SA; Rosen JM
    BMC Biol; 2016 Jun; 14():47. PubMed ID: 27317311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.